about
Significant reduction of left atrial volume concomitant with clinical improvement after percutaneous transluminal septal myocardial ablation for drug-refractory hypertrophic obstructive cardiomyopathy, and its precise detection with multidetector CTExpression of cyclin D1 and CDK4 causes hypertrophic growth of cardiomyocytes in culture: a possible implication for cardiac hypertrophyBone marrow-derived cells contribute to pulmonary vascular remodeling in hypoxia-induced pulmonary hypertension.Are the effects of alpha-glucosidase inhibitors on cardiovascular events related to elevated levels of hydrogen gas in the gastrointestinal tract?The Prevalence of Clinically Significant Ischemia in Patients Undergoing Percutaneous Coronary Intervention: A Report from the Multicenter RegistryComparative data of single versus double proglide vascular preclose technique after percutaneous transfemoral transcatheter aortic valve implantation from the optimized catheter valvular intervention (OCEAN-TAVI) japanese multicenter registry.Prognostic implications of optimal medical therapy in patients undergoing percutaneous coronary intervention for acute coronary syndrome in octogenarians.AVJ-514 Trial - Baseline Characteristics and 30-Day Outcomes Following MitraClip® Treatment in a Japanese Cohort.Transcatheter aortic valve implantation in patients with an extremely small native aortic annulus: The OCEAN-TAVI registry.The incidence, predictive factors and prognosis of acute pulmonary complications after transcatheter aortic valve implantation.Impact of the Clinical Frailty Scale on Outcomes After Transcatheter Aortic Valve Replacement.Incidence and predictors of coronary obstruction following transcatheter aortic valve implantation in the real world.Incidence, Predictors, and Mid-Term Outcomes of Possible Leaflet Thrombosis After TAVR.Incidence, Predictors, and Mid-Term Outcomes of Percutaneous Closure Failure After Transfemoral Aortic Valve Implantation Using an Expandable Sheath (from the Optimized Transcatheter Valvular Intervention [OCEAN-TAVI] Registry).Prognostic value of liver dysfunction assessed by MELD-XI scoring system in patients undergoing transcatheter aortic valve implantation.CT imaging before transcatheter aortic valve implantation (TAVI) using variable helical pitch scanning and its diagnostic performance for coronary artery disease.Impact of underfilling and overfilling in balloon-expandable transcatheter aortic valve implantation assessed by multidetector computed tomography: Insights from the Optimized CathEter vAlvular iNtervention (OCEAN-TAVI) registry.Physical frailty in older people with severe aortic stenosis.Prognostic Value of Hypoalbuminemia After Transcatheter Aortic Valve Implantation (from the Japanese Multicenter OCEAN-TAVI Registry).Pre-procedural dual antiplatelet therapy in patients undergoing transcatheter aortic valve implantation increases risk of bleeding.Comparison of Results of Transcatheter Aortic Valve Implantation in Patients With Versus Without Active Cancer.Real-World Use and Appropriateness of Coronary Interventions for Chronic Total Occlusion (from a Japanese Multicenter Registry).Delivery balloon-induced ascending aortic dissection: An unusual complication during transcatheter aortic valve implantation.Streamlining the learning process for TAVI: Insight from a comparative analysis of the OCEAN-TAVI and the massy registries.Elevation of B-Type Natriuretic Peptide at Discharge is Associated With 2-Year Mortality After Transcatheter Aortic Valve Replacement in Patients With Severe Aortic Stenosis: Insights From a Multicenter Prospective OCEAN-TAVI (Optimized TranscatheteAppropriateness of coronary interventions in Japan by the US and Japanese standards.Usefulness of a Simple Clinical Risk Prediction Method, Modified ACEF Score, for Transcatheter Aortic Valve Implantation.Glucocorticoid protects rodent hearts from ischemia/reperfusion injury by activating lipocalin-type prostaglandin D synthase-derived PGD2 biosynthesis.Is postdilatation useful after implantation of the Edwards valve?Renal function-based contrast dosing predicts acute kidney injury following transcatheter aortic valve implantation.Transfemoral aortic valve implantation new criteria to predict vascular complications.Transfemoral aortic valve implantation in patients with an annulus dimension suitable for either the Edwards valve or the CoreValve.First direct comparison of clinical outcomes between European and Asian cohorts in transcatheter aortic valve implantation: the Massy study group vs. the PREVAIL JAPAN trial.Multidetector computed tomography-guided percutaneous transluminal septal myocardial ablation in a Noonan syndrome patient with hypertrophic obstructive cardiomyopathy.Comparison of multislice computed tomography findings between bicuspid and tricuspid aortic valves before and after transcatheter aortic valve implantation.Impact of frailty markers on outcomes after transcatheter aortic valve replacement: insights from a Japanese multicenter registry.Inhalation of hydrogen gas reduces infarct size in the rat model of myocardial ischemia-reperfusion injury.Safety and efficacy of minimalist approach in transfemoral transcatheter aortic valve replacement: insights from the Optimized transCathEter vAlvular interventioN-Transcatheter Aortic Valve Implantation (OCEAN-TAVI) registry.Transcatheter aortic valve implantation in patients of small body size.A proctoring system to manage the learning curve associated with the introduction of transcatheter aortic valve implantation in Japan.
P50
Q24658440-1938F305-6A61-4E88-BADA-4D8C74ACFC4FQ28576549-ED2260FE-0CFB-451A-A9B7-4B7B71DD8DA7Q33214950-8CFEF1B6-0204-4573-A198-844A2C683F8AQ33442816-8A3AAB29-2E7C-4161-B333-D97CFB23B73BQ35731501-2A1D5220-BA99-41EC-9AA0-A9398409E873Q36175643-FB0F7E9D-643F-4382-9C7F-C319735EE7A8Q38184952-1B5BB38B-385B-494C-B5D1-CDA3D44CB122Q38379259-C664E922-DEFF-468F-8DB1-1A6478CB168BQ38729235-79BC3AA7-5932-4A21-BF74-6100B229C8E2Q38814399-2B4640DE-411A-4CDF-8CDE-4A37179ECA2BQ38902480-6B1E9B0D-32C9-4AF3-8609-538F44E4428BQ38906452-97B56F74-746F-4EBA-B086-B7D0C7C28757Q39065590-06C2FABF-B4D9-4498-8A05-53452E0BBA88Q39113081-C32A0CCB-B321-4989-B49E-97B26FAE8226Q39156382-4BDDB778-F2E9-40D1-ACAE-99AC3AFB4E21Q39452770-A635AEB2-24E6-4A5D-BB04-628C1846F4A9Q39493248-F0D1B2A7-9834-47FA-82CC-C7474B374ABDQ40235970-A4359AC0-AD9A-41D2-90E1-10F2AACA74E4Q40408260-FB6E20CE-827B-4C28-9ADF-674B93CCA5F9Q40615659-EF2500C7-6B76-49C8-AB81-8DB9E1F019C5Q40691010-DA8DC5F9-2458-4CA5-BD50-C4E9A4BAF1B4Q40727040-2C952B0F-6BAE-4EE9-A535-2B6C1B20A9C1Q40950496-8C70FD8C-38C9-47CF-98D0-C311A2B932A5Q41195728-D02E6F08-2A2C-4823-A2E2-4A842917C1EFQ41627435-660BE67F-2E2C-421C-930F-92507C9DECB2Q41744526-F5BB6C60-0349-47DF-9568-D223041DE91AQ41757772-F5301723-D02A-4447-B26D-0B788A260795Q41889468-5B12E774-4C25-4C28-B243-0997BFF8639BQ43454887-000BC02C-0C47-45F6-8E69-B662E195846EQ43505214-BC2A4AE2-23E0-4AF1-A25B-F8BC13A3DC24Q44345250-8720CBF4-A480-4D21-8D1F-F70A17EB52A9Q44602141-DB078A37-56FC-4B36-945E-F462F772CD6BQ44792674-43003575-383D-4053-9BE4-1FF98B4E3D7EQ45710730-CF6301F6-0151-4CA5-80D7-EA9F73C6E57BQ46718309-571EC7F7-1008-44DD-8943-7E5A90970188Q47107586-6A146623-A51B-4A6B-BA6D-6FEFAE0549EAQ47230432-4827F27E-DED9-4322-9853-564DF31306FFQ47235780-F971BCC3-ACAE-4D4C-A275-B0EEB0ACECC2Q47239418-DEF8F3AE-B82F-45D5-BF61-6528B1CE78E2Q47259359-DB461C22-53D2-451B-878B-FE6E45AB94AB
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Kentaro Hayashida
@ast
Kentaro Hayashida
@en
Kentaro Hayashida
@es
Kentaro Hayashida
@nl
Kentaro Hayashida
@sl
type
label
Kentaro Hayashida
@ast
Kentaro Hayashida
@en
Kentaro Hayashida
@es
Kentaro Hayashida
@nl
Kentaro Hayashida
@sl
prefLabel
Kentaro Hayashida
@ast
Kentaro Hayashida
@en
Kentaro Hayashida
@es
Kentaro Hayashida
@nl
Kentaro Hayashida
@sl
P1053
J-5071-2014
P106
P1153
55568279500
P21
P31
P3829
P496
0000-0002-1750-1982